Archives

by in
Entry Author Date Location
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) 05/14/13 National
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Fighting a Global War on Rare Diseases 03/20/13 New York
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Veracyte Wins Over UnitedHealth With Thyroid Cancer Diagnostic 03/08/13 San Francisco
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
FDA OKs First-in-Class Drug From Isis for Rare Cholesterol Disorder 01/29/13 San Diego
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Xconomy Boston’s Top 20 Stories of the Year: Editor’s Picks 12/26/12 Boston
Xconomist of the Week: Alexis Borisy Still Likes Early Stage Biotechs 12/20/12 Boston
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round 12/20/12 San Francisco
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing 11/29/12 Boston
Selecta in Development Deal with Sanofi Worth up to $900 Million 11/28/12 Boston
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Celgene, Sanofi, Stryker Execs Charged With Insider Trading 11/19/12 New York
Janssen Forms “Investigator Databank” to Help Streamline Drug Trials 11/15/12 San Diego
San Diego’s Regulus Therapeutics Readies for IPO This Week 10/01/12 San Diego
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.